Key result
Prolonged Tp-e interval linked to recurrent life-threatening events in Brugada syndrome.
Why the study?
The study aimed to evaluate Tpeak-Tend interval and other ECG parameters as risk factors for life-threatening cardiac events in patients with Brugada syndrome.
Do Tpeak-Tend interval and Tpeak-Tend dispersion predict the recurrence of life-threatening cardiac events in patients with Brugada syndrome?
Case-Control (n=58)
Do Tpeak-Tend interval and Tpeak-Tend dispersion predict the recurrence of life-threatening cardiac events in patients with Brugada syndrome?
Tpeak-Tend interval and its dispersion are significantly prolonged in Brugada syndrome patients with recurrent life-threatening arrhythmias, suggesting their utility for risk stratification.
OBJECTIVES: Our objective in this study was to evaluate Tpeak-Tend interval (Tp-e) and other electrocardiographic parameters as risk factors for recurrence of life-threatening cardiac events in patients with the Brugada syndrome (BS). BACKGROUND: The Tp-e interval in the electrocardiogram (ECG) has been reported to predict life-threatening arrhythmias in the long QT syndrome. METHODS: Twenty-nine patients with the ECG pattern of BS and 29 healthy age- and gender-matched controls were studied. The follow-up period was 42.65 +/- 24.42 months (range 11 to 108 months). RESULTS: Upon presentation, five patients had suffered aborted sudden death, five syncope, and two presyncope. Eleven patients with the ECG pattern of BS had a prolonged (>460 ms) QTc in V2 but usually not in inferior or left leads. No patient had abnormally prolonged QT dispersion. Programmed electrical stimulation induced ventricular tachycardia/fibrillation in 5 out of 26 patients. Inducibility did not predict recurrence of events. Cardioverter-defibrillators were implanted in 14 patients (all symptomatic and two asymptomatic). During follow-up, nine symptomatic patients experienced recurrences. Previous cardiac events and a QTc >460 ms in V2 were significant risk factors (p = 0.00002 and p = 0.03, respectively). Tp-e and Tp-e dispersion were significantly prolonged in patients with recurrences versus patients without events (104.4 and 35.6 ms vs. 87.4 and 23.2 ms; p = 0.006 and p = 0.03, respectively) or controls (90.7 and 17.9 ms; p = 0.02 and p = 0.001, respectively). CONCLUSIONS: Our study demonstrates significant correlation between previous events, QTc >460 ms in V2, Tp-e, and Tp-e dispersion and occurrence of life-threatening arrhythmic events, suggesting that these parameters may be useful in risk stratification of patients with the Brugada syndrome.
No takes yet. Share an insight, caveat, or question.
Hevia et al. (2006) conducted a case-control in Brugada syndrome (n=58). Tpeak-Tend (Tp-e) interval and Tp-e dispersion vs. Patients without recurrences and healthy controls was evaluated on Recurrence of life-threatening cardiac events (p=0.006). Prolonged Tp-e (104.4 vs 87.4 ms; p=0.006) and Tp-e dispersion (35.6 vs 23.2 ms; p=0.03) were significantly associated with the recurrence of life-threatening events in Brugada syndrome patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: